WITHDRAWN: The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication

Lifen Wang; Zhiming Ye; Huaban Liang; Bin Zhang; Lixia Xu; Zhonglin Feng; Shuangxin Liu; Wei Shi

doi:10.1016/j.cca.2016.01.020

WITHDRAWN: The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication

Clin Chim Acta. 2016 Jan 22:S0009-8981(16)30019-5. doi: 10.1016/j.cca.2016.01.020. Online ahead of print.

Authors

Lifen Wang¹, Zhiming Ye¹, Huaban Liang¹, Bin Zhang¹, Lixia Xu¹, Zhonglin Feng¹, Shuangxin Liu¹, Wei Shi²

Affiliations

¹ Department of Nephrology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
² Department of Nephrology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. Electronic address: shiwei1593@163.com.

PMID: 26807867
DOI: 10.1016/j.cca.2016.01.020

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Publication types

Retraction of Publication